
ACE Inhibitors Global Market Report 2025
Description
ACE Inhibitors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ace inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for ace inhibitors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ace inhibitors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Sulfhydryl-containing Agents; Dicarboxylate-containing Agents; Phosphonate-containing Agents
2) By Drug: Ramipril; Enalapril; Benazepril; Fosinopril; Captopril; Moexipril; Other Drugs
3) By Dosage Form: Oral Tablets; Oral Solutions
4) By Application: Heart Failure; Chronic Kidney Disease; Hypertension; Diabetes; Heart Attack; Other Applications
5) By End-Users: Hospitals; Online Drug Stores; Other End-Users
Subsegments:
1) By Sulfhydryl-Containing Agents: Captopril; Zofenopril
2) By Dicarboxylate-Containing Agents: Enalapril; Lisinopril; Ramipril; Quinapril; Benazepril; Perindopril
3) By Phosphonate-Containing Agents: Fosinopril
Companies Mentioned: Pfizer Inc.; Novartis AG; Johnson & Johnson Private Limited; Merck KGaA; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on ace inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ace inhibitors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ace inhibitors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Sulfhydryl-containing Agents; Dicarboxylate-containing Agents; Phosphonate-containing Agents
2) By Drug: Ramipril; Enalapril; Benazepril; Fosinopril; Captopril; Moexipril; Other Drugs
3) By Dosage Form: Oral Tablets; Oral Solutions
4) By Application: Heart Failure; Chronic Kidney Disease; Hypertension; Diabetes; Heart Attack; Other Applications
5) By End-Users: Hospitals; Online Drug Stores; Other End-Users
Subsegments:
1) By Sulfhydryl-Containing Agents: Captopril; Zofenopril
2) By Dicarboxylate-Containing Agents: Enalapril; Lisinopril; Ramipril; Quinapril; Benazepril; Perindopril
3) By Phosphonate-Containing Agents: Fosinopril
Companies Mentioned: Pfizer Inc.; Novartis AG; Johnson & Johnson Private Limited; Merck KGaA; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. ACE Inhibitors Market Characteristics
- 3. ACE Inhibitors Market Trends And Strategies
- 4. ACE Inhibitors Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global ACE Inhibitors Growth Analysis And Strategic Analysis Framework
- 5.1. Global ACE Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global ACE Inhibitors Market Growth Rate Analysis
- 5.4. Global ACE Inhibitors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global ACE Inhibitors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global ACE Inhibitors Total Addressable Market (TAM)
- 6. ACE Inhibitors Market Segmentation
- 6.1. Global ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sulfhydryl-containing Agents
- Dicarboxylate-containing Agents
- Phosphonate-containing Agents
- 6.2. Global ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ramipril
- Enalapril
- Benazepril
- Fosinopril
- Captopril
- Moexipril
- Other Drugs
- 6.3. Global ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Tablets
- Oral Solutions
- 6.4. Global ACE Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Heart Failure
- Chronic Kidney Disease
- Hypertension
- Diabetes
- Heart Attack
- Other Applications
- 6.5. Global ACE Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Online Drug Stores
- Other End-Users
- 6.6. Global ACE Inhibitors Market, Sub-Segmentation Of Sulfhydryl-Containing Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Captopril
- Zofenopril
- 6.7. Global ACE Inhibitors Market, Sub-Segmentation Of Dicarboxylate-Containing Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Enalapril
- Lisinopril
- Ramipril
- Quinapril
- Benazepril
- Perindopril
- 6.8. Global ACE Inhibitors Market, Sub-Segmentation Of Phosphonate-Containing Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Fosinopril
- 7. ACE Inhibitors Market Regional And Country Analysis
- 7.1. Global ACE Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global ACE Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific ACE Inhibitors Market
- 8.1. Asia-Pacific ACE Inhibitors Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China ACE Inhibitors Market
- 9.1. China ACE Inhibitors Market Overview
- 9.2. China ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India ACE Inhibitors Market
- 10.1. India ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan ACE Inhibitors Market
- 11.1. Japan ACE Inhibitors Market Overview
- 11.2. Japan ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia ACE Inhibitors Market
- 12.1. Australia ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia ACE Inhibitors Market
- 13.1. Indonesia ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea ACE Inhibitors Market
- 14.1. South Korea ACE Inhibitors Market Overview
- 14.2. South Korea ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe ACE Inhibitors Market
- 15.1. Western Europe ACE Inhibitors Market Overview
- 15.2. Western Europe ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK ACE Inhibitors Market
- 16.1. UK ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany ACE Inhibitors Market
- 17.1. Germany ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France ACE Inhibitors Market
- 18.1. France ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy ACE Inhibitors Market
- 19.1. Italy ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain ACE Inhibitors Market
- 20.1. Spain ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe ACE Inhibitors Market
- 21.1. Eastern Europe ACE Inhibitors Market Overview
- 21.2. Eastern Europe ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia ACE Inhibitors Market
- 22.1. Russia ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America ACE Inhibitors Market
- 23.1. North America ACE Inhibitors Market Overview
- 23.2. North America ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA ACE Inhibitors Market
- 24.1. USA ACE Inhibitors Market Overview
- 24.2. USA ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada ACE Inhibitors Market
- 25.1. Canada ACE Inhibitors Market Overview
- 25.2. Canada ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America ACE Inhibitors Market
- 26.1. South America ACE Inhibitors Market Overview
- 26.2. South America ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil ACE Inhibitors Market
- 27.1. Brazil ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East ACE Inhibitors Market
- 28.1. Middle East ACE Inhibitors Market Overview
- 28.2. Middle East ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa ACE Inhibitors Market
- 29.1. Africa ACE Inhibitors Market Overview
- 29.2. Africa ACE Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa ACE Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa ACE Inhibitors Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. ACE Inhibitors Market Competitive Landscape And Company Profiles
- 30.1. ACE Inhibitors Market Competitive Landscape
- 30.2. ACE Inhibitors Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 31. ACE Inhibitors Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. Teva Pharmaceutical Industries Ltd.
- 31.3. Bristol-Myers Squibb Co.
- 31.4. Takeda Pharmaceuticals Company
- 31.5. Daiichi Sankyo Company Ltd.
- 31.6. UCB Schwarz Pharma Inc.
- 31.7. Endo International plc
- 31.8. Sun Pharmaceutical Industries Ltd.
- 31.9. Boehringer Ingelheim
- 31.10. Bausch Health Companies Inc.
- 31.11. Dr. Reddy's Laboratories
- 31.12. Abbott Laboratories
- 31.13. Eli Lilly and Company
- 31.14. Cipla Limited
- 31.15. GlaxoSmithKline plc
- 32. Global ACE Inhibitors Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The ACE Inhibitors Market
- 34. Recent Developments In The ACE Inhibitors Market
- 35. ACE Inhibitors Market High Potential Countries, Segments and Strategies
- 35.1 ACE Inhibitors Market In 2029 - Countries Offering Most New Opportunities
- 35.2 ACE Inhibitors Market In 2029 - Segments Offering Most New Opportunities
- 35.3 ACE Inhibitors Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.